BBOT
BridgeBio Oncology Therapeutics, Inc.
4.10$
+4.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.02 | |
| – | – | – | – | -0.02 | |
| – | – | 2.75 | 5,665.89 | 3.89 | |
| 0.00 | 0.00 | 0.41 | 601.10 | 0.79 | |
| 0.00 | 0.00 | 3.16 | 6,266.99 | 4.68 | |
| 0.00 | 0.00 | -3.16 | -6,266.99 | -4.68 | |
| 0.00 | 0.00 | -3.16 | -5,756.41 | -4.30 | |
| 0.00 | 0.00 | -3.16 | -5,756.41 | -4.30 | |
| 0.00 | 0.00 | -3.16 | -6,250.87 | -4.66 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.